114 related articles for article (PubMed ID: 2530869)
1. Pharmacodynamics of amlodipine: hemodynamic effects and antianginal efficacy after atrial pacing.
Hogg KJ; Hornung RS; Hillis WS; Gupta S; Grant P; Singh SP
Am Heart J; 1989 Nov; 118(5 Pt 2):1107-13. PubMed ID: 2530869
[TBL] [Abstract][Full Text] [Related]
2. Anti-anginal efficacy of intravenous amlodipine assessed by means of atrial pacing.
Hogg KJ; Hornung RS; Hillis WS; Gupta S; Grant P; Singh SP
Postgrad Med J; 1991; 67 Suppl 5():S57-8. PubMed ID: 1839443
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist.
Vetrovec GW; Dailey S; Kay G; Epstein A; Plumb V
Postgrad Med J; 1991; 67 Suppl 5():S60-1. PubMed ID: 1839444
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
Detry JM; De Coster PM; Renkin J
Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
[TBL] [Abstract][Full Text] [Related]
5. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
[TBL] [Abstract][Full Text] [Related]
6. Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease.
Lipkin DP; Poole-Wilson PA
Int J Cardiol; 1985 Nov; 9(3):303-10. PubMed ID: 2865217
[TBL] [Abstract][Full Text] [Related]
7. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
9. A double-blind dose-response study of amlodipine in patients with stable angina pectoris.
Cocco G; Alfiero R
Eur Heart J; 1991 Feb; 12(2):169-74. PubMed ID: 1828420
[TBL] [Abstract][Full Text] [Related]
10. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
Silke B; Goldhammer E; Sharma SK; Verma SP; Taylor SH
Cardiovasc Drugs Ther; 1990 Apr; 4(2):457-63. PubMed ID: 2149514
[TBL] [Abstract][Full Text] [Related]
11. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
Glasser SP; West TW
Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788
[TBL] [Abstract][Full Text] [Related]
12. Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris.
Ikram H; Low CJ; Shirlaw T; Webb CM; Richards AM; Crozier IG
Am J Cardiol; 1990 Jul; 66(2):164-7. PubMed ID: 2196774
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
[TBL] [Abstract][Full Text] [Related]
14. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W
Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085
[TBL] [Abstract][Full Text] [Related]
15. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
16. Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease.
Silke B; Frais MA; Midtbo KA; Verma SP; Sharma S; Reynolds G; Jackson N; Taylor SH
Clin Pharmacol Ther; 1987 Oct; 42(4):381-7. PubMed ID: 2959425
[TBL] [Abstract][Full Text] [Related]
17. Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion.
Feldman RL; Hill JA; Conti CR; Pepine CJ
J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):318-25. PubMed ID: 3968317
[TBL] [Abstract][Full Text] [Related]
18. Effects of felodipine on systemic and coronary haemodynamics in patients with angina pectoris.
Emanuelsson H; Hjalmarson A; Holmberg S; Waagstein F
Eur Heart J; 1984 Apr; 5(4):308-16. PubMed ID: 6734641
[TBL] [Abstract][Full Text] [Related]
19. Coronary heart disease. Differential hemodynamic, metabolic, and electrocardiographic effects in subjects with and without angina pectoris during atrial pacing.
Helfant RH; Forrester JS; Hampton JR; Haft JI; Kemp HG; Gorlin R
Circulation; 1970 Oct; 42(4):601-10. PubMed ID: 11993303
[TBL] [Abstract][Full Text] [Related]
20. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Davies GJ; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
